A Comparison of Short- and Long-Term Soy Protein Isolate Intake and Its Ability to Reduce Liver Steatosis in Obese Zucker Rats Through Modifications of Genes Involved in Inflammation and Lipid Transport

다국어 초록 (Multilingual Abstract)

Obesity can lead to several health disorders including nonalcoholic fatty liver disease (NAFLD), the aggregation of lipids within hepatocytes, and consequent inflammation of the liver tissue. Previously, we reported that feeding obese Zucker rats with soy protein isolate (SPI) can reduce liver steatosis. To understand how SPI reduced liver steatosis, we conducted global gene expression analysis on liver samples obtained from these rats after short- (8 weeks) and long-term SPI feeding (16 weeks). We compared and contrasted these data using Ingenuity Pathway Analysis (IPA) software. This study focused mainly on target molecules that could be participating in inflammation processes and lipid metabolism that are well-known components of NAFLD. Inflammatory response was predicted to be inhibited in animals fed the SPI diet at both 8 and 16 weeks of experiment. This general prediction was based on negative activation z scores obtained through IPA (z score < −2.0, P < .00001) for eight aspects of immune function/inflammatory response. Lipid metabolism was predicted to be strongly enhanced in rats fed the SPI diet for 16 weeks than for 8 weeks. This prediction was based on positive activation z scores (z scores >2.0, P < .00001) of eight functions involved in lipid transport and metabolism. We observed that the longer the rats were fed the SPI diet, the more beneficial it resulted against NAFLD. Based on our findings, the predicted reductions in inflammatory mechanisms while enhancing lipid transport out of the liver could be the reasons behind the reduction of liver steatosis.

참고문헌 (Reference)

1 Woodcock JM, "Three residues in the common beta chain of the human GM-CSF, IL-3 and IL-5receptors are essential for GM-CSF and IL-5 but not IL-3 high affinity binding and interact with Glu21 of GM-CSF" 13 : 5176-5185, 1994

2 Uchimura K, "The serine protease prostasin regulates hepatic insulin sensitivity by modulating TLR4 signalling" 5 : 3428-3440, 2014

3 Buzzetti E, "The multiple-hit pathogenesis of non-alcoholic fatty liver disease(NAFLD)" 65 : 1038-1048, 2016

4 Meighan-Mantha RL, "The mitogeninducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration" 274 : 33166-33176, 1999

5 Garlanda C, "The interleukin-1family : Back to the future" 39 : 1003-1018, 2013

6 Feng SL, "The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas" 156 : 1253-1261, 2000

7 Jiang S, "TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice" 62 : 371-379, 2015

8 Reza Hakkak, "Short- and Long-Term Soy Diet Versus Casein Protects Liver Steatosis Independent of the Arginine Content" 한국식품영양과학회 18 (18): 1274-1280, 2015

9 Chen S, "Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with nonalcoholic fatty liver disease : A randomized controlled trial" 47 : 226-232, 2015

10 Park JK, "Quantitative analysis of NPTX2hypermethylation is a promising molecular diagnostic marker for pancreatic cancer" 35 : e9-e15, 2007

11 Hales CM, "Prevalence of obesity and severe obesity among adults : United States, 2017–2018" 360 : 1-8, 2020

12 Kakino S, "Pivotal role of TNF-a in the development and progression of nonalcoholic fatty liver disease in a murine model" 50 : 80-87, 2018

13 Fang YL, "Pathogenesis of nonalcoholic fatty liver disease in children and adolescence: From ‘‘two hit theory’’ to ‘‘multiple hit model.’’" 24 : 2974-2983, 2018

14 Gu J, "Nonalcoholic lipid accumulation and hepatocyte malignant transformation" 4 : 123-130, 2016

15 Moschen AR, "Non-alcoholic steatohepatitis : A microbiota-driven disease" 24 : 537-545, 2013

16 Castan˜o-Rodrı´guez N, "NAFLD, Helicobacter species and the intestinal microbiome" 31 : 657-668, 2017

17 Kincaid HJ, "Microbiome-immune-metabolic axis in the epidemic of childhood obesity : Evidence and opportunities" 21 : 1-13, 2020

18 Kawano Y, "Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease" 48 : 434-441, 2013

19 Mortazavi A, "Mapping and quantifying mammalian transcriptomes by RNASeq" 5 : 621-628, 2008

20 Kozaczek M, "Liver transcriptomic analysis after short- and longterm feeding of soy protein isolate and its ability to reduce liver steatosis in obese zucker rats" University of Arkansas 2020

21 Auguet T, "Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease" 121 : 119-124, 2013

22 Tilg H, "Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis" 64 : 955-965, 2016

23 Hotamisligil GS, "Inflammation, metaflammation and immunometabolic disorders" 542 : 177-185, 2017

24 Sun Z, "IL-33-ST2 axis in liver disease : Progression and challenge" 2017 : 5314213-, 2017

25 Zaiss MM, "IL-1b suppresses innate IL-25 and IL-33 production and maintains helminth chronicity" 9 : e1003531-, 2013

26 Mirea AM, "IL-1 family cytokine pathways underlying NAFLD : Towards new treatment strategies" 24 : 458-471, 2018

27 Freese K, "Histone deacetylase expressions in hepatocellular carcinoma and functional effects of histone deacetylase inhibitors on liver cancer cells in vitro" 11 : 1587-, 2019

28 Charrez B, "Hepatocellular carcinoma and non-alcoholic steatohepatitis : The state of play" 22 : 2494-2502, 2016

29 Francisco-Cruz A, "Granulocyte-macrophage colony-stimulating factor : Not just another haematopoietic growth factor" 31 : 774-, 2014

30 Pejnovic N, "Galectin-3 and IL-33/ST2 axis roles and interplay in dietinduced steatohepatitis" 22 : 9706-9717, 2016

31 Alwahsh SM, "Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver" 20 : 1807-1821, 2014

32 Niederreiter L, "Cytokines and fatty liver diseases" 2 : 14-20, 2018

33 Kozaczek M, "Comparison of liver gene expression by RNAseq and PCR analysis after 8 weeks of feeding soy protein isolate-or casein-based diets in an obese liver steatosis rat model" 10 : 8218-8229, 2019

34 Kern PA, "Adiponectin expression from human adipose tissue : Relation to obesity, insulin resistance, and tumor necrosis factor-a expression" 52 : 1779-1785, 2003

35 Tilg H, "A role for IL-1 inhibitors in the treatment of non-alcoholic fatty liver disease (NAFLD)?" 29 : 103-106, 2020